Comment
Death from P. falciparum infection in subjects who live in areas of stable malaria is usually due either to cerebral involvement or to the consequences of anaemia (Edington and Gilles, 1969) .
Almost all the data on increased resistance against malaria have been obtained in A/S heterozygotes, and there is no a priori reason to expect that they should apply to S/S homozygotes. In addition, one can envisage some mechanisms whereby malaria might actually lead to death in the homozygote. (1) A patient with sicklecell disease suffers from chronic anaemia. The superimposed haemolysis from acute malaria infection may precipitate anaemic heart failure. This occurred in our case. (2) Malaria might act as a trigger for intravascular sickling (Edington, 1953) . Parasitized cells from A/S heterozygotes tend to sickle more readily than non-parasitized cells (Luzzatto et al., 1970) , a phenomenon which facilitates their trapping by a normal reticuloendothelial system. However, when a major component of that system, the spleen, is atrophied as a result of sickle-cell disease (as in our patient), parasitized cells will continue to circulate and the parasitaemia may threaten life.
In conclusion, we suggest that in our case, and in that of Rey et al. (1966) , the S gene in double dose failed to protect against severe malaria and the peculiar interaction between this genetic abnormality and malarial infection led to the fatal outcome.
Haemostatic failure in early infancy, when associated with prolongation of the prothrombin time, is usually ascribed to "haemorrhagic disease of the newborn." This disease is a temporary deficiency of the vitamin-K dependent coagulation factors II, VII, IX, and X, and it responds to the administration of vitamin K. The following case reports illustrate a more unusual cause of prolongation of the prothrombin time in two siblings with haemostatic failure.
Case 1
A male infant, the third child of healthy unrelated parents whose previous two children were well, was born at term after an uneventful pregnancy; birth weight 3,800 g. He was discharged home at 48 hours on a cow's milk formula and did not receive additional vitamin K. At 9 days he was readmitted in extremis and died soon afterwards of massive subarachnoid and gastrointestinal bleeding. The prothrombin time on admission was longer than 60 seconds. Necropsy confirmed the diagnosis of subarachnoid haemorrage and a firm yellow brown liver was found, histological examination of which showed widespread parenchymal cell necrosis with massive fatty infiltration and early bile duct proliferation (see Fig.) . Because the prothrombin time had been greatly prolonged a diagnosis of haemorrhagic disease of the newborn had been made; the hepatocellular necrosis was unexplained at the time. This infant, the sister of Case 1, was born also at term after a normal pregnancy; birth weight 3,080 g. She received vitamin K1 (Konakion) 1 mg intramuscularly after birth and was fed with a cow's milk formula. At 3 weeks she was readmitted because she was vomiting and weighed 300 g less than at birth. Her umbilicus was infected but she did not have hepatosplenomegaly and there were no other abnormal physical signs. Femoral venepuncture resulted in a large haematoma and continuous oozing of blood for over 10 hours.
Coagulation studies (see Table) showed not only abnormalities of the vitamin-K dependent factors VII and X but also a reduction in factor V and fibrinogen and an increase in factor VIII. There was no response to parenteral administration of vitamin K. These features were strongly suggestive of severe liver disease. At this stage she became clinically jaundiced (bilirubin: total 5 mg/100 ml, conjugated 3 mg/100 ml) and other tests of hepatocellular function became abnormal (5-nucleotidase 191 IU, lactic dehydrogenase 630 IU, isocitrate dehydrogenase 120 IU).
The early onset of a familial haemorrhagic tendency and hepatic damage was suggestive of an inborn error of metabolism. Normal red-cell levels of galactose-l-phosphate uridyl transferase excluded diagnosis of galoctosaemia. The presence of fructose in the urine, together with estimations of blood sugars which sh.owed higher levels of total reducing substances than of glucose (glucose oxidase method), by implying the diagnosis of fructosaemia, suggested a diagnosis of hereditary fructose intolerance. Nevertheless, the plasma tyrosine level of 6 mg/100 ml was also raised and the urine contained large amounts of the phenolic acids characteristic of acute tyrosinosis.
A fructose-free and sucrose-free diet was started, and within three days the jaundice faded, the vomiting stopped, and she began to gain weight rapidly. The return of the plasma tyrosine to normal feature of hereditary fructose intolerance, may result in failure of glucose production and bilirubin excretion and abnormalities of tyrosine metabolism; acute tyrosinosis, noticeable in Case 2, may sometimes dominate the clinical picture (Lindemann et al., 1969 and the disappearance of the phenolic acids from the urine indicated that the acute tyrosinosis had been secondary to hepatocellular failure. Levels of coagulation factors returned to normal. A test dose of fructose given by mouth at 6 weeks of age precipitated hypoglycaemia (blood glucose fell to 11 mg/100 ml) and confirmed the diagnosis of hereditary fructose intolerance. In the ensuing months on a fructose-free diet her physical and developmental progress were normal.
Comment
Though the bleeding diathesis in Case 1 was ascribed to haemorrhagic disease of the newborn on account of a prolonged prothrombin time, the feeding history and age of onset were not typical of this condition. Haemorrhagic disease of the newborn occurs in the first week of life in breast-fed infants who have not received vitamin K (Sutherland et al., 1967) . Vitamin-K responsive haemorrhagic disease may occur in older infants but is usually associated with gastrointestinal disturbance or antibiotic administration (Goldman and Deposito, 1966) . By contrast the disturbance of haemostasis which occurs in severe liver disease is distinguished by failure of the prothrombin factors to improve after vitamin-K therapy, together with an additional impairement of synthesis of factor V and fibrinogen (Ratnoff, 1963) and raised factor VIlI (Meili and Straub, 1970) . This pattern of abnormalities is clearly shown in Case 2. In these two siblings the cause of hepatic dysfunction was hereditary fructose intolerance, a rare inborn error of metabolism characterized by deficiency of hepatic fructose-lphosphate aldolase (Froesch, 1966) . The diagnosis in Case 1 was not made in life, but is strongly suggested in retrospect by his relationship to Case 2 and by the distinctive hepatic changes seen at necropsy, which are similar to those reported in fatal cases in older infants. Hepatocellular damage, a prominent been a prolongation of the prothrombin time, but one of the seven cases reported by Levin et al. (1968) had a low plasma fibrinogen level. In one of our patients bleeding was the initial and lethal symptom, and in the other full investigation of the cause of bleeding pointed to a diagnosis of a metabolic disorder.
These two cases show that bleeding due to impaired synthesis of coagulation factors may be an early symptom of a metabolic disease and illustrate the need for full investigation of all bleeding problems in early infancy, especially when the history and preliminary findings are not typical of vitamin-K responsive haemorrhagic disease.
